Michael G. Rusnak is the Executive Director for MUSC Foundation for Research Development
Mr. Rusnak has over 25 years of life science experience most recently holding the position of Director of New Ventures and Technology Development within the technology transfer office at the University of Rochester Medical Center. In his six year tenure at Rochester he led the office in life science licensing and directed the University’s Technology Development Fund and the award process. Mr. Rusnak also played a lead role in additional fund raising, including SBIRs and STTRs, for the Fund’s applicants, pre and post award. Mr. Rusnak additionally established numerous collaborations to foster commercialization, further investments, and advance drug discovery including agreements with the Moulder Center for Drug Discovery Research at Temple University, the Medical Research Council in the United Kingdom, Califia Bio, Inc., and Johnson & Johnson.
Michael may be reached at: email@example.com or
Previous to Rochester, he was an entrepreneur-in-residence with BCM Technologies, Inc. the venture subsidiary of Baylor College of Medicine where he was involved in starting and incubating more than five spinout companies from the medical school. Mr. Rusnak has held senior positions in biotechnology business development with Ceros Pharmaceuticals, CombiChem and Lexicon Genetics, among others, where he was involved in over $100 million of partnering activity in the areas of drug discovery, combinatorial chemistry, and genomics.
Prior to Lexicon he held various positions in marketing, sales, and project management with Baxter, Bayer, and Cetus. Mr. Rusnak received his Master’s Degree in Clinical Science/Lab Management from San Francisco State University and has a B.S. in Microbiology from St. Bonaventure University.